About QuVa Pharma
QuVa Pharma is a company based in Sugar Land (United States) founded in 2015. QuVa Pharma has raised $15 million across 4 funding rounds from investors including SVB, Bain Capital Private Equity and Oxford Finance. QuVa Pharma has completed 1 acquisition, including LogicStream. QuVa Pharma offers products and services including Compounded Sterile Preparations and Featured Medical Products.
- Headquarter Sugar Land, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quva Pharma
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 4 rounds
-
Latest Funding Round
$41 M (USD), Debt – Venture
Jul 24, 2018
-
Investors
SVB
& 3 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QuVa Pharma
QuVa Pharma offers a comprehensive portfolio of products and services, including Compounded Sterile Preparations and Featured Medical Products.
Compounded sterile preparations are supplied by QuVa Pharma for medical fields including anesthesia and pain management, ensuring compliance with quality standards
Featured medical products such as syringes and gels are offered by QuVa Pharma in ready-to-administer formats, supporting efficient healthcare delivery
People of QuVa Pharma
Unlock access to complete
Software Development Team
16 people
Leadership Team
14 people
Sales and Marketing
8 people
Operations Team
5 people
Legal and Compliance
2 people
Data Analysis and Operations Team
2 people
Product Management Team
1 people
Human Resources and Administration
1 people
Unlock access to complete
Funding Insights of QuVa Pharma
QuVa Pharma has successfully raised a total of $15M across 4 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $41 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in QuVa Pharma
QuVa Pharma has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Bain Capital Private Equity and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Customized lease financing solutions are offered by Farnam Street Financial.
|
Locked | Locked | Locked | |
|
Private investment firm managing assets and expanding into equity, credit, and real estate services.
|
Locked | Locked | Locked |
Investor details for QuVa Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QuVa Pharma
QuVa Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include LogicStream.
Investment portfolio details for QuVa Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical decision support is optimized for healthcare through EHR solutions.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for QuVa Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - QuVa Pharma
Detailed financials for QuVa Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quva Pharma Comparisons
Peer comparison for QuVa Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QuVa Pharma
Detailed competitors of QuVa Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quva Pharma
Complete news archive for QuVa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QuVa Pharma
QuVa Pharma was founded in 2015.
QuVa Pharma is headquartered in Sugar Land, United States. It is registered at Sugar Land, Texas, United States.
QuVa Pharma is a funded company, having raised a total of $15M across 4 funding rounds to date.
QuVa Pharma provides the platform for sterile compounding pharmacy services. It supplies vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. It acquired the assets of the Unique Pharmaceuticals including 503B Compounding Pharmacy Services (Division of Healix) which provides ready-to-use compounded sterile preparations to hospitals. It provides specialty admixtures in IV bags (LVPs and piggy-backs), syringes, cassette and in specialized PCA vials.
QuVa Pharma offers Compounded Sterile Preparations and Featured Medical Products.
QuVa Pharma has made 1 acquisition, including LogicStream.
QuVa Pharma has 4 investors. Key investors include SVB, Bain Capital Private Equity, Oxford Finance, and Farnam Street Financial.